NCT05950802View on ClinicalTrials.gov

Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
DLBCL - Diffuse Large B Cell Lymphoma
Interventions
DRUG

Cyclophosphamide

Higher dose than traditional conditioning chemo

RADIATION

TLI

radiation given with conditioning chemo

Trial Locations (1)

Unknown

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER